These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hereditary progressive levodopa sensible: Segawa's syndrome]. Grippo J; La Fuente A; Corral SM; Grippo T Rev Neurol; 2002 May 16-31; 34(10):933-6. PubMed ID: 12134322 [TBL] [Abstract][Full Text] [Related]
4. [Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study]. Litvinenko IV; Odinak MM; Mogil'naia VI; Sologub OS; Sakharovskaia AA Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):51-4. PubMed ID: 19156087 [TBL] [Abstract][Full Text] [Related]
5. A case report of dopa-responsive dystonia. Tang X; Li Y Chin Med Sci J; 2001 Jun; 16(2):123-4. PubMed ID: 12901504 [No Abstract] [Full Text] [Related]
6. Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia. Nygaard TG; Takahashi H; Heiman GA; Snow BJ; Fahn S; Calne DB Ann Neurol; 1992 Nov; 32(5):603-8. PubMed ID: 1449240 [TBL] [Abstract][Full Text] [Related]
7. Anaesthesia for caesarean section in a patient with dopa-responsive dystonia or Segawa's syndrome. Sinha A; Hartsilver EL Int J Obstet Anesth; 2009 Jan; 18(1):67-72. PubMed ID: 19022657 [TBL] [Abstract][Full Text] [Related]
8. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations. de la Fuente-Fernández R Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251 [TBL] [Abstract][Full Text] [Related]
9. Dopa-responsive dystonia (Segawa disease) -like disease accompanied by mental retardation: a case report. Nagata E; Kosakai A; Tanaka K; Segawa M; Fujioka H; Shintaku H; Suzuki N Mov Disord; 2007 Jun; 22(8):1202-3. PubMed ID: 17469209 [No Abstract] [Full Text] [Related]
10. Misdiagnoses in children with dopa-responsive dystonia. Jan MM Pediatr Neurol; 2004 Oct; 31(4):298-303. PubMed ID: 15464646 [TBL] [Abstract][Full Text] [Related]
12. Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson's disease. Chen H; Fang J; Li F; Gao L; Feng T Neurol Sci; 2015 Jul; 36(7):1217-23. PubMed ID: 25616444 [TBL] [Abstract][Full Text] [Related]
13. Gastroretentive carbidopa/levodopa, DM-1992, for the treatment of advanced Parkinson's disease. Verhagen Metman L; Stover N; Chen C; Cowles VE; Sweeney M Mov Disord; 2015 Aug; 30(9):1222-8. PubMed ID: 25847690 [TBL] [Abstract][Full Text] [Related]
14. Levodopa for Dystonia in Children: A Case Series and Review of the Literature. DeArias AL; Bamford NS Pediatr Neurol; 2024 Mar; 152():16-19. PubMed ID: 38176223 [TBL] [Abstract][Full Text] [Related]
16. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Fahn S; J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436 [TBL] [Abstract][Full Text] [Related]
17. [The effect of controlled release of DOPA and carbidopa on clinical response and plasma pharmacokinetics of DOPA in parkinsonian patients]. García de Yébenes J; Mateo D; Pino MA; Cordero M; Pastor M; Chacón J; Morales B; Sánchez V; Mena MA; Giménez Roldán S Neurologia; 1997 Apr; 12(4):145-56. PubMed ID: 9235023 [TBL] [Abstract][Full Text] [Related]
18. A family with hereditary juvenile dystonia-parkinsonism. Ishikawa A; Miyatake T Mov Disord; 1995 Jul; 10(4):482-8. PubMed ID: 7565830 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Snow BJ; Nygaard TG; Takahashi H; Calne DB Ann Neurol; 1993 Nov; 34(5):733-8. PubMed ID: 8239569 [TBL] [Abstract][Full Text] [Related]